GoldH.: Clinical Pharmacology of Digoxin, J. Pharmacol. Exptl. Therap.109: 45–57 (Sept.-Dec.) 1953.
2.
DohertyJ. E.PerkinsW. H.MitchellG. K.: Tritiated Digoxin Studies in Human Subjects, Arch. Internal Med.108: 531–539 (Oct.) 1961.
3.
BraunwaldE.KlockeF. J.: Digitalis, Ann. Rev Med.16: 371–386, 1965.
4.
MarcusF. I.: Administration of Tritiated Digoxin with and without a Loading Dose, Circulation34: 865–874 (Nov.) 1966.
5.
GoodmanL. S.GilmanA.: “The Pharmacological Basis of Therapeutics,”MacMillan Co., N. Y., 1965, pp. 155–156.
6.
GravensteinJ. S.: Pharmacology for the Preoperative Visit, Intern. Anesthesiology Clinics6: 312–314 (Spring) 1968.
7.
KiorboeE.PlumC.: Megaloblastic Anemia Developing During Treatment of Epilepsy, Acta Med. Scand.179: (Suppl. 445) 349–357 (Apr. 17) 1966.
8.
DahlkeM.Mertens-RoeslerE.: Malabsorption of Folic Acid Due to Diphenylhydantoin, Blood30: 341–351 (Sept.) 1967.
9.
WishinskyHenryGlasserElainePerkalStuart: Protein Interactions of Sulfonylurea Compounds, Diabetes11: (Suppl.) 18–25, 1962.
10.
KristensenM.HansenJ.: Potentiation of the Tolbutamide Effect by Dicoumarol, Diabetes16: 211–214 (Apr.), 1967.
11.
MorrelliHowardMelmonKenneth: The Clinician's Approach to Drug Interactions, Calif. Med.109: 380–389 (Nov.) 1968.
12.
GreenbergP.SanfordJ.: Removal and Absorption of Antibiotics in Patients with Renal Failure Undergoing Peritoneal Dialysis, Ann. Internal Med.66: 465–479 (Mar.) 1967.
13.
BulgerR.BennettJ.BornS.: Intraperitoneal Administration of Broad-Spectrum Antibiotics in Patients with Renal Failure, J. Am. Med. Assoc.194: 1198–1202 (Dec. 13) 1965.
14.
ScagliettiO.MarchettiP.: Prophylactic Value of Local Treatment with Chloramphenicol in the Surgery of Lumbar Discs, Postgrad. Med. J.Suppl. 43: 94–96 (Mar.) 1967.